Remove 2003 Remove Drugs Remove Pharmaceuticals Remove Testimonials
article thumbnail

The FDA and Feasible Alternative Designs

Drug & Device Law

Drug manufacturers often could trade a little less efficacy for a little more safety, but the safest design is not always the best one. to determine whether a proposed alternative drug would have received FDA approval.” 2003), aff’d , 810 N.Y.S.2d For physicians to prescribe such a safer drug, it must reach the market.

FDA 59
article thumbnail

Not the Best Wisconsin Law Decision We’ve Ever Seen

Drug & Device Law

The surgeon’s testimony supported two grounds for non-causation: lack of reliance, and that a warning would not have changed how the prescription product was used. Wyeth Pharmaceuticals , 471 F. 2003 WL 1785795, at *13 (D. One certainly doesn’t find this distinction at the Zimmer Nexgen language that Rennick cited.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Unimpressed Learned Intermediaries Defeat Warning Causation

Drug & Device Law

That means that prescribers can make risk/benefit analyses to determine what prescription drugs or medical devices their patients need. The prescriber’s] testimony, however, does not establish that he would have altered his prescribing conduct. That “common and widely known side effect” of many “chemotherapy drugs,” id.

article thumbnail

On Expert “Adulteration” and “Misbranding” Opinions

Drug & Device Law

Ferring Pharmaceuticals, Inc. A lot of the discussion in Tsao was case specific because the purported expert opinions at issue were among the most ridiculous we’ve ever seen – directly contrary to the controlling FDA regulations applicable to the particular drug. High on the list was Tsao v. 2018 WL 3649714 (S.D. April 19, 2018).

article thumbnail

Guest Post – More on Expert Gatekeeping in West Virginia

Drug & Device Law

In the “ 50-State Survey of State Court Decisions Supporting Expert-Related Judicial Gatekeeping ,” the Drug & Device Law Blog (the Best Blog on the Planet) describes West Virginia as a “gatekeeper” state because of cases reflecting adoption of the Daubert analysis of W. 2003) (citation and quotation marks omitted); see also State v.